cyanidin has been researched along with chronic COVID syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arjsri, P; Dejkriengkraikul, P; Mapoung, S; Semmarath, W; Srisawad, K; Thippraphan, P; Umsumarng, S; Yodkeeree, S | 1 |
1 other study(ies) available for cyanidin and chronic COVID syndrome
Article | Year |
---|---|
Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inf
Topics: Anthocyanins; COVID-19; Glucosides; Humans; Inflammasomes; Interleukin-18; Lung; Macrophages; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oryza; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |